Literature DB >> 25547150

Ischaemic strokes with reversible vasoconstriction and without thunderclap headache: a variant of the reversible cerebral vasoconstriction syndrome?

Valérie Wolff1, Jean-Paul Armspach, Valérie Lauer, Olivier Rouyer, Anne Ducros, Christian Marescaux, Bernard Gény.   

Abstract

BACKGROUND: Reversible vasoconstriction (RV) may cause ischaemic stroke (IS) in the absence of any other defined stroke aetiology. The three objectives of our study were to evaluate the frequency of RV in a prospective series of young IS patients, to describe the detailed clinical-radiological features in the patients with RV and IS, and to compare these characteristics with those of reversible cerebral vasoconstriction syndrome (RCVS).
METHODS: We identified between October 2005 and December 2010, 159 consecutive young patients (<45 years) hospitalized for an acute IS confirmed by cerebral magnetic resonance imaging. An extensive diagnostic work-up was performed including toxicological urinary screening for cannabis, cocaine and amphetamines, and the usual biological, cardiac and vascular investigations for an IS in the young. We specifically studied patients with IS and RV, which was defined as multifocal intracranial arterial stenoses confirmed by intracranial arterial imaging that resolved within 3-6 months.
RESULTS: Out of 159 patients with IS, 21 (13%, 12 males, 9 females; mean age 32 years) had multifocal cerebral arterial stenoses that were fully reversible at 3-6 months, and no other cause for stroke. IS were located on posterior territory in 71% of cases, and vasoconstriction predominated on posterior cerebral and superior cerebellar arteries. Precipitating factors of IS and RV were the use of cannabis resin (n = 14), nasal decongestants (n = 2) and triptan (n = 1). Most cases (74%) had unusual severe headache, but none had thunderclap headache. None of 21 cases had reversible posterior leukoencephalopathy, cortical subarachnoid or intracerebral haemorrhage.
CONCLUSION: RV was the sole identified cause of IS in 13% of our cohort. These young patients with IS and RV may have a variant of RCVS, related to an increased susceptibility to vasoactive agents in some individuals. RV in our patients differs from the classical characteristics of RCVS by the absence of thunderclap headache, reversible brain oedema and subarachnoid or intracranial haemorrhage. Intracranial arteries should be looked for, by appropriate vascular imaging, in young patients with IS at the acute stage and during the follow-up period.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25547150     DOI: 10.1159/000369776

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  13 in total

Review 1.  Role of cannabis in cardiovascular disorders.

Authors:  Hemant Goyal; Hamza H Awad; Jalal K Ghali
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Assessing the public health impacts of legalizing recreational cannabis use: the US experience.

Authors:  Wayne Hall; Michael Lynskey
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

3.  Recovery from spinal cord infarction associated with cannabis use.

Authors:  Tamer Akel
Journal:  J Spinal Cord Med       Date:  2017-01-30       Impact factor: 1.985

Review 4.  What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review.

Authors:  Emilie Jouanjus; Valentin Raymond; Maryse Lapeyre-Mestre; Valérie Wolff
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

5.  Marijuana and Microcirculation: A Review.

Authors:  Pramod Theetha Kariyanna; Leanna R Smith; Karishma Patwa; Moro O Salifu; Isabel M McFarlane
Journal:  Am J Med Case Rep       Date:  2020-06-05

6.  Is the Presence of Headache Indispensable in Diagnosing Reversible Cerebral Vasoconstriction Syndrome?

Authors:  Byung Su Kim; Yun Kyung Park; Mun Kyung Sunwoo; Hyun Jeung Yu; Eun Hye Jeong; Dae Yoon Kim
Journal:  J Clin Neurol       Date:  2019-10       Impact factor: 3.077

Review 7.  A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse.

Authors:  Aristides Tsatsakis; Anca Oana Docea; Daniela Calina; Konstantinos Tsarouhas; Laura-Maria Zamfira; Radu Mitrut; Javad Sharifi-Rad; Leda Kovatsi; Vasileios Siokas; Efthimios Dardiotis; Nikolaos Drakoulis; George Lazopoulos; Christina Tsitsimpikou; Panayiotis Mitsias; Monica Neagu
Journal:  J Clin Med       Date:  2019-08-23       Impact factor: 4.241

Review 8.  Harmful Effects of Smoking Cannabis: A Cerebrovascular and Neurological Perspective.

Authors:  Sabrina Rahman Archie; Luca Cucullo
Journal:  Front Pharmacol       Date:  2019-12-06       Impact factor: 5.810

9.  Marijuana use and pregnancy outcomes among women with hypertension in pregnancy.

Authors:  Karen S Greiner; Jamie O Lo; Rosa J Speranza; Mónica Rincón; Richard M Burwick
Journal:  J Matern Fetal Neonatal Med       Date:  2020-07-06

Review 10.  A Systematic Review of the Complex Effects of Cannabinoids on Cerebral and Peripheral Circulation in Animal Models.

Authors:  J Sebastian Richter; Véronique Quenardelle; Olivier Rouyer; Jean Sébastien Raul; Rémy Beaujeux; Bernard Gény; Valérie Wolff
Journal:  Front Physiol       Date:  2018-05-29       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.